Intermedia.NET Company Profile

01:55 EDT 18th March 2018 | BioPortfolio

Intermedia.NET is the number one US provider of hosted Exchange and Web hosting for small and mid-sized businesses (SMBs). Since 1995, we have given smaller companies the same enterprise-strength IT as large corporations, but delivered as a service over the Internet for a low monthly fee – instead of a large upfront investment.By paying just a few dollars per month for each employee, these smaller companies gain access to the same business email and software that Fortune 500 companies use. And because Intermedia.NET runs these hosted services from our world-class datacenters, which are managed round the clock by a large group of specialist technicians and engineers, they gain Fortune 500-level robustness – quality service with no email downtime. We also provide world-class 24x7 customer support, with extremely knowledgeable staff constantly on hand


156 W 56th Street, suite 1601
New York
New York
United States of America


Phone: 1-212-375-6375
Fax: 1-212-245-1766

News Articles [0 Results]


PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

Ecology suitability study of Ephedra intermedia.

The study aims at predicting ecological suitability of Ephedra intermedia in China by using maximum entropy Maxent model combined with GIS, and finding the main ecological factors affecting the distri...

Taxonomic study on Japanese Salvia (Lamiaceae): Phylogenetic position of S. akiensis, and polyphyletic nature of S. lutescens var. intermedia.

Both Salvia akiensis and S. lutescens (Lamiaceae) are endemic to Japan. Salvia akiensis was recently described in 2014 in the Chugoku (= SW Honshu) region, and each four varieties of S. lutescens dist...

Full structure and insight into the gene cluster of the O-specific polysaccharide of Yersinia intermedia H9-36/83 (O:17).

Lipopolysaccharide was isolated from bacteria Yersinia intermedia H9-36/83 (O:17) and degraded with mild acid to give an O-specific polysaccharide, which was isolated by GPC on Sephadex G-50 and studi...

Restriction-modification mediated barriers to exogenous DNA uptake and incorporation employed by Prevotella intermedia.

Prevotella intermedia, a major periodontal pathogen, is increasingly implicated in human respiratory tract and cystic fibrosis lung infections. Nevertheless, the specific mechanisms employed by this p...

Biocidal potential and chemical composition of industrial essential oils from Hyssopus officinalis, Lavandula x intermedia var. super and Santolina chamaecyparissus.

This work presents the biocidal (insecticidal, ixodicidal, nematicidal and phytotoxic) effects and chemical compositions of three essential oils obtained from the industrial steam distillation (IEOs) ...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia

The purpose of this study is determination of the efficacy of combination of hydroxyurea with L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients w...

Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia

Thalassemia intermedia (TI) is an inherited blood disorder that can cause anemia due to low levels of hemoglobin. Decitabine is a medication that may be effective at increasing hemoglobin ...

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

OBJECTIVES: I. Determine whether arginine butyrate with or without epoetin alfa can stimulate gamma-globin chain production to a degree that decreases anemia and results in hematologic im...

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

The purpose of this study is to evaluate the safety and tolerability of HQK-1001 administered daily for 8 weeks in subjects with beta thalassemia intermedia

The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital

The primary objective is to assess the prevalence and genotypes of HCV infection in thalassemia major and thalassemia intermediate patients who have received blood transfusion in the Depar...

Companies [2 Associated Companies listed on BioPortfolio]


Intermedia.NET is the number one US provider of hosted Exchange and Web hosting for small and mid-sized businesses (SMBs). Since 1995, we have given smaller companies the same enterprise-strength IT a...

Inter/Media Advertising

Inter/Media Advertising is a fully integrated $450-million advertising agency and media organization that uniquely blends direct response advertising with general market techniques. Founded in 1974 a...

More Information about "Intermedia.NET" on BioPortfolio

We have published hundreds of Intermedia.NET news stories on BioPortfolio along with dozens of Intermedia.NET Clinical Trials and PubMed Articles about Intermedia.NET for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intermedia.NET Companies in our database. You can also find out about relevant Intermedia.NET Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record